Suite

Claritas Announces New Registered and Records Office Address, Confirms its Management and Directors and Announces Terms of Initial Tranche of Equity Financing with Alumina Partners

Retrieved on: 
Monday, January 17, 2022 - 12:00pm
Civic, Board, Patient, SAN, CLAS, Exercise, CAD, Price, Suite, Board of directors, Unit, CA, Times New Roman, CEO, Solution, GLOBE, OTC, Director, Agreement, Company, Drug development, CFO, TSX Venture Exchange, Market, TSX, LLC, FAHA, Market price support, Security (finance), Pharmaceutical industry, BC, Aluminium oxide

The Companys head office continues to be located at 4040 Civic Center Drive, Suite 200, San Rafael, California, 94903, USA.

Key Points: 
  • The Companys head office continues to be located at 4040 Civic Center Drive, Suite 200, San Rafael, California, 94903, USA.
  • Under the Agreement, Claritas may draw down, at its option and subject to certain conditions, cash tranches of up to $250,000 each.
  • Claritas Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing therapies for patients with significant unmet medical needs.
  • Claritas leverages its expertise to find solutions that will improve health outcomes and dramatically improve people's lives.

Revelstone Capital Acquisition Corp. Announces Closing of $15 Million Over-Allotment Option in Connection with Its Initial Public Offering

Retrieved on: 
Saturday, January 15, 2022 - 4:59am
Professional Services, Finance, Telephone, Forward-looking statement, SPAC, 3rd Floor, SEC, Suite, Risk, Roth Capital Partners, Nasdaq, BofA Securities, Attention, U.S. Securities and Exchange Commission, Acquisition, Company, Sale, LLC, Security (finance), Prospectus, Financial services

Revelstone Capital Acquisition Corp. (the Company or Revelstone) announced that the underwriters in its initial public offering partially exercised their over-allotment option and today purchased an additional 1,500,000 units at $10.00 per unit.

Key Points: 
  • Revelstone Capital Acquisition Corp. (the Company or Revelstone) announced that the underwriters in its initial public offering partially exercised their over-allotment option and today purchased an additional 1,500,000 units at $10.00 per unit.
  • The gross proceeds from the partial option exercise were $15 million before deducting underwriting discounts and expenses.
  • BofA Securities and Roth Capital Partners acted as joint-book running managers in the offering.
  • This press release contains statements that constitute forward-looking statements, including with respect to the initial public offering and search for an initial business combination.

SOL Global Investments Corp. Acquires Stock of Atmofizer Technologies Inc. to Increase Holding To 10.00%

Retrieved on: 
Saturday, January 15, 2022 - 12:19am
Professional Services, Natural Resources, Other Natural Resources, Finance, Nature, Indian stock exchange, SEDAR, Bentall, News, CAD, Suite, National instrument, COVID-19, Perception, Canadian Securities Exchange, Public opinion, Ownership, Hospitality, Phrase, Company, Related, USD, QSR, CSE, Projection, Warrant, Transaction, SOL, Burrard Street, Risk, Security (finance), Risk management, Agriculture

This news release, and the early warning report filed in connection with the Transaction, was filed late due to administrative error.

Key Points: 
  • This news release, and the early warning report filed in connection with the Transaction, was filed late due to administrative error.
  • Since the date of the Transaction, SOL Global has continued to trade securities of ATMO in the ordinary course on the CSE.
  • As of the date hereof, SOL Global holds approximately 9.0% of the issued and outstanding Common Shares on a non-diluted basis.
  • About SOL Global Investments Corp.
    SOL Global is a diversified investment and private equity holding company engaged in the small and mid-cap sectors.

Welsbach Technology Metals Acquisition Corp. Announces Partial Exercise of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering

Retrieved on: 
Friday, January 14, 2022 - 9:10pm
Forward-looking statement, Exercise, SEC, Suite, Risk, NASDAQ, Nasdaq, GLOBE, State Street, U.S. Securities and Exchange Commission, Acquisition, Industry, Company, Sale, Security (finance), Prospectus

The Companys units commenced trading on the Nasdaq Global Market (Nasdaq) on December 28, 2021, under the ticker symbol WTMAU.

Key Points: 
  • The Companys units commenced trading on the Nasdaq Global Market (Nasdaq) on December 28, 2021, under the ticker symbol WTMAU.
  • While the Company may pursue an acquisition in any business industry or sector, it intends to concentrate its efforts on targets in the technology metals and energy transition materials industry.
  • A registration statement relating to these securities has been filed with, and declared effective by, the SEC on December 27, 2021.
  • The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

ACE Convergence Acquisition Corp. and Tempo Automation, Inc. Announce Additional Funding to Trust

Retrieved on: 
Friday, January 14, 2022 - 9:13pm
Software, Technology, Other Manufacturing, Manufacturing, Semiconductor, Sponsor, Tempo Automation, Business architecture, SEC, 100,000, Industry, Form 10-K, DE, Register, Vii, Nasdaq, Probability, COVID-19, XV, Extension, Electronics, Reading, Registration statement, Failure, Annual report, U.S. Securities and Exchange Commission, Forward-looking statement, Proxy, ACE, SEC filing, Securities Act of 1933, Acquisition, Xi, Person, Form S-1, Suite, Automation, Compass, Form, Sale, Risk, Business, Prospectus, Security (finance), Risk management, Ownership

As previously announced on October 14, 2021, Tempo and ACE, along with ACE Convergence Subsidiary Corp., entered into an agreement and plan of merger relating to their proposed business combination.

Key Points: 
  • As previously announced on October 14, 2021, Tempo and ACE, along with ACE Convergence Subsidiary Corp., entered into an agreement and plan of merger relating to their proposed business combination.
  • Tempo and ACE currently expect the transaction to be closed, subject to respective shareholder approvals, in Q1 or Q2 2022.
  • ACE Convergence Acquisition Corp. (Nasdaq: ACEV) is a $230 million special purpose acquisition company focusing on industrial and enterprise IT and semiconductors.
  • Neither Tempo Automation nor ACE gives any assurance that either Tempo Automation or ACE, respectively, will achieve its expectations.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Desktop Metal, Inc. (DM)

Retrieved on: 
Friday, January 14, 2022 - 6:30pm
Metal, News, GPM, Desktop Metal, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Suite, NYSE, GLOBE, Solution, EnvisionTEC, Court, Time, Lists of schools in England, Company, Food, Defendant, DM, Medical device, 3D printing, Animal

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
  • On February 16, 2021, Desktop Metal acquired EnvisionTEC, Inc. and certain of its affiliates (collectively, EnvisionTEC), a provider of volume production photopolymer 3D printing solutions for end use parts.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

DEADLINE ALERT for BLI, PSFE, RVNC, RAAS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Friday, January 14, 2022 - 6:30pm
People's Law Office, Telephone, Research, Law, Biotechnology, IPO, Suite, NYSE, Human, Solution, GLOBE, Class, Gambling, BFT, Time, Paysafe, Company, Investment, E-commerce, Digital wallet, FDA, RAAS, Security (finance), Risk management, Pharmaceutical industry, Beacon

BENSALEM, Pa., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .
  • Law Offices of Howard G. Smith

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Arrival SA (ARVL)

Retrieved on: 
Friday, January 14, 2022 - 6:30pm
News, GPM, EBITDA, Suite, NASDAQ, GLOBE, EVS, Court, Time, Lists of schools in England, Company, Defendant, Complaint, Animal

On November 8, 2021, Arrival released its third quarter financial results, which revealed a loss of 26 million and an adjusted EBITDA loss of 40 million.

Key Points: 
  • On November 8, 2021, Arrival released its third quarter financial results, which revealed a loss of 26 million and an adjusted EBITDA loss of 40 million.
  • On this news, Arrivals stock price fell $4.33, or 24%, to close at $13.46 per share on November 10, 2021, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Reata Pharmaceuticals, Inc. (RETA)

Retrieved on: 
Friday, January 14, 2022 - 6:30pm
Lasso, Alport syndrome, Patient, Alport, News, GPM, Kidney, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Suite, Advisory Committee, Safety, NASDAQ, GLOBE, Court, Time, Chronic kidney disease, Lists of schools in England, Risk, Food, AS, FDA, Defendant, DNA methylation, Trial of the century, Investment, Pharmaceutical industry, Animal

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
  • If you purchased or otherwise acquired Reata securities during the Class Period, you may move the Court no later than February 18, 2022 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Oak Street Health, Inc. (OSH)

Retrieved on: 
Friday, January 14, 2022 - 6:30pm
Legal, Professional Services, Telephone, News, Law, OSH, Oak, Suite, Oak Street, NYSE, CID, DOJ, Court, Time, Law enforcement, Lists of schools in England, Company, United States Department of Justice, False Claims Act, Risk, Defendant, Transport, Security (finance), Pharmaceutical industry

Investors suffering losses on their Oak Street investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .

Key Points: 
  • Investors suffering losses on their Oak Street investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .
  • On November 8, 2021, Oak Street disclosed that on November 1, 2021 the Company received a civil investigative demand (CID) from the United States Department of Justice (DOJ).
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.